Home Cart 0 Sign in  
X

[ CAS No. 1227585-65-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1227585-65-0
Chemical Structure| 1227585-65-0
Chemical Structure| 1227585-65-0
Structure of 1227585-65-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1227585-65-0 ]

Related Doc. of [ 1227585-65-0 ]

Alternatived Products of [ 1227585-65-0 ]

Product Details of [ 1227585-65-0 ]

CAS No. :1227585-65-0 MDL No. :MFCD16606984
Formula : C6H5BrClNO Boiling Point : -
Linear Structure Formula :- InChI Key :PCMSIEWNWZBDPO-UHFFFAOYSA-N
M.W : 222.47 Pubchem ID :71721408
Synonyms :

Calculated chemistry of [ 1227585-65-0 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 43.07
TPSA : 33.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.51 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.81
Log Po/w (XLOGP3) : 1.62
Log Po/w (WLOGP) : 1.84
Log Po/w (MLOGP) : 1.25
Log Po/w (SILICOS-IT) : 2.52
Consensus Log Po/w : 1.81

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.62
Solubility : 0.536 mg/ml ; 0.00241 mol/l
Class : Soluble
Log S (Ali) : -1.93
Solubility : 2.63 mg/ml ; 0.0118 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.33
Solubility : 0.104 mg/ml ; 0.000468 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.84

Safety of [ 1227585-65-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338-P310 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1227585-65-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1227585-65-0 ]
  • Downstream synthetic route of [ 1227585-65-0 ]

[ 1227585-65-0 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 137628-17-2 ]
  • [ 1227585-65-0 ]
YieldReaction ConditionsOperation in experiment
93%
Stage #1: With isopropyl magnesium chloride - lithium chloride complex In tetrahydrofuran at -40 - 20℃; for 1 h;
Stage #2: at 20℃; for 0.5 h;
Stage #3: With sodium tetrahydroborate In methanol; water at 5℃; for 1 h;
To a solution of 2,3-dibromo-5-chloropyridine (60 g, 221 mmol) in THF (500 mL) was added a solution of isopropylmagnesium chloride lithium chloride solution in THF (1.3M, 185 mL) at −40° C. over about 30 min. The solution was stirred for 30 min at −40° C. and DMF (50 mL) was added. The resulting solution was warmed up to room temperature and stirred for 30 min. The reaction was quenched with 1 N HCl (400 mL) and MTBE (200 mL) was added. Organic layer was separated and washed twice with 5percent aqueous NaHCO3 (200 mL). The solvent was removed under vacuum at 50° C. The resulting solids (aldehyde intermediate) were dissolved in methanol (400 mL). The solution was cooled to 5° C. under an ice bath. NaBH4 (3.6 g) was added slowly over 30 min while maintaining the reaction temperature below room temperature. The reaction mixture was stirred for another 30 min followed by addition of water (125 mL). The resulting mixture was concentrated under vacuum to approximately 150 ml. Solids precipitated during the concentration. The suspension was stirred vigorously at room temperature for 1 h and solids were collected by filtration. The wet cake was dried in a vacuum oven over night at 60° C. to give 52 (45.6 g, 93percent) as a solid. 1H NMR (CDCl3, 400 MHz): δ 8.26 (d, J=2.5 Hz, 1H), 7.88 (d, J=2.5 Hz, 1H), 4.73 (d, J=5.8 Hz, 2H), 2.33 (t, J=11.4 Hz, 1H); 13C NMR (CDCl3, 100 MHz): δ 147.12, 138.48, 138.39, 136.14, 132.06, 62.76.
Reference: [1] Patent: US2016/130273, 2016, A1, . Location in patent: Paragraph 0234; 0235
[2] Patent: WO2013/138413, 2013, A1,
[3] Patent: WO2013/169348, 2013, A1,
[4] Angewandte Chemie - International Edition, 2014, vol. 53, # 32, p. 8375 - 8378[5] Angew. Chem., 2014, vol. 126, # 32, p. 8515 - 8518,4
[6] Organic Process Research and Development, 2017, vol. 21, # 11, p. 1851 - 1858
  • 2
  • [ 1227605-52-8 ]
  • [ 1227585-65-0 ]
YieldReaction ConditionsOperation in experiment
93% at 5 - 20℃; for 1 h; To a solution of 2,3-dibromo-5-chloropyridine (60 g, 221 mmol) in THF (500 mL) was added a solution of isopropylmagnesium chloride lithium chloride solution in THF (1.3M, 185 mL) at -40 °C over about 30 min. The solution was stirred for 30 min at -40 °C and DMF (50 mL) was added. The resulting solution was warmed up to room temperature and stirred for 30 min. The reaction was quenched with 1 N HCl (400 mL) and MTBE (200 mL) was added. Organic layer was separated and washed twice with 5percent aqueous NaHC03 (200 mL). The solvent was removed under vacuum at 50 °C. The resulting solids (aldehyde intermediate) were dissolved in methanol (400 mL). The solution was cooled to 5 °C under an ice bath. NaBtit (3.6 g) was added slowly over 30 min while maintaining the reaction temperature below room temperature. The reaction mixture was stirred for another 30 min followed by addition of water (125 mL). The resulting mixture was concentrated under vacuum to approximately 150 ml. Solids precipitated during the concentration. The suspension was stirred vigorously at room temperature for 1 h and solids were collected by filtration. The wet cake was dried in a vacuum oven over night at 60 °C to give 1 (45.6 g, 93percent) as a solid. 1H NMR (CDC13) 400 MHz): <5 8.26 (d, J= 2.5 Hz, 1H), 7.88 (d, J=2.5 Hz, IK), 4.73 (d, J= 5.8 Hz, 2H), 2.33 (t, J= 1 1.4 Hz, 1H); 13C NMR (CDC13, 100 MHz): δ 147.12, 138.48, 138.39, 136.14, 132.06, 62.76.
45.6 g at 5 - 20℃; for 1 h; To a solution of 2,3-dibromo-5-chloropyridine (60 g, 221 mmol) in THF (500 mL) was added a solution of isopropylmagnesium chloride lithium chloride solution in THF (1 .3M, 185 mL) at -40 °C over about 30 mm. The solution was stirred for 30 mm at -40 °C and DMF (50 mL) was added. The resulting solution was warmed up to room temperature and stirred for 30 min. The reaction was quenched with 1 N HCl (400 mL) and MTBE (200 mL) was added. Organic layer was separated and washed twice with 5percent aqueous NaHCO3 (200 mL). The solvent was removed under vacuum at 50 °C. The resulting solids (aldehyde intermediate) were dissolved in methanol (400 mL). The solution was cooled to 5 °C under an ice bath. NaBH4 (3.6 g) was added slowly over 30 min while maintaining the reaction temperature below room temperature. The reaction mixture was stirred for another 30 min followed by addition of water (125 mL). The resulting mixture was concentrated under vacuum to approximately 150 ml. Solids precipitated during the concentration. The suspension was stirred vigorously at room temperature for 1 h and solids were collected by filtration. The wet cake was dried in a vacuum oven over night at 60 °C to give 52 (45.6 g, 93percent) as a solid. 1H NMR (CDCl3, 400 MHz): ö 8.26 (d,J=2.5 Hz, 1H), 7.88 (d,J2.5 Hz, 1H), 4.73 (d,J 5.8 Hz, 2H), 2.33 (t,J= 11.4 Hz, 1H); 13C NMR (CDCl3, 100 MHz): ö 147.12, 138.48, 138.39, 136.14, 132.06, 62.76.
Reference: [1] Patent: WO2013/138413, 2013, A1, . Location in patent: Page/Page column 19; 20
[2] Patent: WO2013/169348, 2013, A1, . Location in patent: Page/Page column 76; 77
[3] Angewandte Chemie - International Edition, 2014, vol. 53, # 32, p. 8375 - 8378[4] Angew. Chem., 2014, vol. 126, # 32, p. 8515 - 8518,4
[5] Organic Process Research and Development, 2017, vol. 21, # 11, p. 1851 - 1858
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1227585-65-0 ]

Bromides

Chemical Structure| 65550-77-8

[ 65550-77-8 ]

2-Bromo-5-chloro-3-methylpyridine

Similarity: 0.87

Chemical Structure| 1227588-48-8

[ 1227588-48-8 ]

2-Bromo-5-chloro-3-(chloromethyl)pyridine

Similarity: 0.81

Chemical Structure| 40473-01-6

[ 40473-01-6 ]

2-Bromo-5-chloropyridine

Similarity: 0.76

Chemical Structure| 1211521-46-8

[ 1211521-46-8 ]

2-Bromo-4-chloro-3-methylpyridine

Similarity: 0.72

Chemical Structure| 925890-48-8

[ 925890-48-8 ]

1-Bromo-4-chloroisoquinoline

Similarity: 0.72

Chlorides

Chemical Structure| 65550-77-8

[ 65550-77-8 ]

2-Bromo-5-chloro-3-methylpyridine

Similarity: 0.87

Chemical Structure| 1227588-48-8

[ 1227588-48-8 ]

2-Bromo-5-chloro-3-(chloromethyl)pyridine

Similarity: 0.81

Chemical Structure| 22620-34-4

[ 22620-34-4 ]

(5-Chloro-3-pyridinyl)methanol

Similarity: 0.78

Chemical Structure| 40473-01-6

[ 40473-01-6 ]

2-Bromo-5-chloropyridine

Similarity: 0.76

Chemical Structure| 1211521-46-8

[ 1211521-46-8 ]

2-Bromo-4-chloro-3-methylpyridine

Similarity: 0.72

Alcohols

Chemical Structure| 22620-34-4

[ 22620-34-4 ]

(5-Chloro-3-pyridinyl)methanol

Similarity: 0.78

Chemical Structure| 55483-88-0

[ 55483-88-0 ]

(2,6-Dibromopyridin-3-yl)methanol

Similarity: 0.71

Chemical Structure| 1003711-43-0

[ 1003711-43-0 ]

2-Bromo-5-hydroxy-3-methylpyridine

Similarity: 0.70

Chemical Structure| 58498-61-6

[ 58498-61-6 ]

5-Chloro-3-methylpyridin-2-ol

Similarity: 0.70

Chemical Structure| 127561-70-0

[ 127561-70-0 ]

2-Bromo-5-chloropyridin-3-ol

Similarity: 0.68

Related Parent Nucleus of
[ 1227585-65-0 ]

Pyridines

Chemical Structure| 65550-77-8

[ 65550-77-8 ]

2-Bromo-5-chloro-3-methylpyridine

Similarity: 0.87

Chemical Structure| 1227588-48-8

[ 1227588-48-8 ]

2-Bromo-5-chloro-3-(chloromethyl)pyridine

Similarity: 0.81

Chemical Structure| 22620-34-4

[ 22620-34-4 ]

(5-Chloro-3-pyridinyl)methanol

Similarity: 0.78

Chemical Structure| 40473-01-6

[ 40473-01-6 ]

2-Bromo-5-chloropyridine

Similarity: 0.76

Chemical Structure| 1211521-46-8

[ 1211521-46-8 ]

2-Bromo-4-chloro-3-methylpyridine

Similarity: 0.72